The thesis
Evidence you can inspect.
PsychDoc.AI is Violema's first research application. PsychDoc.AI connects claims about psychedelic research to the studies behind them. Its research publishing and evidence synthesis make sources, limitations and open questions visible.
It helps researchers, science writers and teams evaluating research inspect study populations, measurements and limitations.
It is a research surface. It does not provide medical or legal advice, dosing, therapy, or treatment recommendations.
What it is
Research publishing and evidence synthesis.
PsychDoc.AI connects psychedelic research claims to source studies through evidence maps and transparent research synthesis.
The first public dossier asks whether a single dose of psilocybin rewires the brain. Its evidence map connects papers and claims. Study limitations and revision history remain visible. Not medical advice.
Live site
PsychDoc.AI live site
PsychDoc.AI, live at psychdoc.ai.
The stage
Live at psychdoc.ai.
PsychDoc.AI was founded in November 2025 and is live at psychdoc.ai. AI tools assist with research and drafting. Automated checks and publisher review do not constitute independent scientific review; independent expert review of the current dossier remains pending. Read the scope and review status.
Approach and research
Keep the evidence attached.
PsychDoc.AI applies Violema's evidence methods to psychedelic research. Its published About page and Terms identify Violema, Inc. as its operator. The application keeps claims connected to their sources and makes review status explicit.
Sources
Inspect the claim
Evidence maps connect claims to the studies behind them.
Scope
Keep the study context
Study populations, measurements and limitations remain visible beside the research question.
Review
Show what was checked
AI assistance, automated checks and publisher review are distinguished from independent scientific review, which remains pending.
Corrections
Keep the record open
Public dossiers retain revision history and provide routes for corrections and review.
Featuring a company or project here does not, by itself, indicate ownership, investment or control by Purple Orange Group. For a product's operator and applicable terms, refer to its own website.
Conviction
A bounded first dossier.
Follow a claim back to its sources.
For product enquiries, use PsychDoc.AI's own website. Explore its evidence map or browse other companies and projects featured here.